New Brunswick

The New Brunswick Cancer Network coordinates services under the Department of Health, and the 2024–25 provincial budget includes CAD 2.9M for screening and oncology drug funding; pancreatic cancer is addressed only within general oncology — no pancreatic-specific program.

Horizon Health's Molecular Oncology Pan Cancer Solid Tumor Panel explicitly lists pancreas as an indication and is available in-province (record dated 1/15/2025), with germline referrals to IWK genetics or in-province clinics; there is no comprehensive funded province-wide program.

This score rests on the Atlantic regional figure — up to 59% of take-home oncology medicine spending was privately paid in the Atlantic groupings vs 12% in Alberta (PMPRB 2021, 2019 data). No NB-specific cost figure was obtainable.

Horizon Health Network has implemented decentralized clinical trials with a digital platform, and NB has a formal collaboration with Nova Scotia for specialized services and shared clinical trials; pancreatic trial access in the region remains assessed as "extremely limited".

NB has no in-province pancreatic surgery — pancreatic surgery is centralized only in Halifax and St. John's — while systemic and radiation therapy are delivered in-province from Horizon hubs in Saint John and Moncton. Not obtainable: no NB-specific wait figure exists; the corpus states only that NB "also has very long wait times".

New Brunswick Medical Transportation covers out-of-province care needs and is rated "Moderate," with the documented gap "limited coverage scope, basic travel assistance only"; lodging exists at Mgr. Henri-Cormier in Moncton, and Ambulance New Brunswick was rated 3 of 5.

The NB Health Human Resource Plan is rated "Partially adequate: broad scope" with a weak cancer/diagnostic workforce focus, and retention weakness is flagged especially for NL and NB; patient navigation is characterized as robust, and Horizon expanded to 12 Indigenous Patient Navigators in 2025.

No CIHR pancreatic-cancer grant is hosted at an NB institution — 0 of 88 records nationally. NB participates in regional research collaboration as one of the four Atlantic Cancer Consortium provinces.